Travere Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $65k | 7.2k | 8.99 |
| 2023-09-30 | $65k | 7.2k | 8.94 |
| 2023-06-30 | $92k | 6.0k | 15.36 |
| 2023-03-31 | $111k | 4.9k | 22.49 |
| 2022-12-31 | $97k | 4.5k | 21.65 |
| 2022-09-30 | $110k | 4.5k | 24.44 |
| 2022-06-30 | $109k | 4.5k | 24.22 |
| 2022-03-31 | $116k | 4.5k | 25.77 |
| 2021-12-31 | $140k | 4.5k | 31.10 |
| 2021-09-30 | $109k | 4.5k | 24.22 |
| 2021-06-30 | $66k | 4.5k | 14.66 |
| 2021-03-31 | $112k | 4.5k | 24.88 |
| 2020-12-31 | $114k | 4.2k | 27.34 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors